| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest
|
Cremolini, Chiara
|
|
2017
|
73 |
C |
p. 74-84
11 p.
|
artikel
|
| 2 |
FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?
|
Modest, D.P.
|
|
2017
|
73 |
C |
p. 71-73
3 p.
|
artikel
|
| 3 |
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy
|
Lees, Justin G.
|
|
2017
|
73 |
C |
p. 22-29
8 p.
|
artikel
|
| 4 |
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study
|
Ursu, Renata
|
|
2017
|
73 |
C |
p. 30-37
8 p.
|
artikel
|
| 5 |
MAPK pathway in melanoma part II—secondary and adaptive resistance mechanisms to BRAF inhibition
|
Amaral, Teresa
|
|
2017
|
73 |
C |
p. 93-101
9 p.
|
artikel
|
| 6 |
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
|
Cuzzubbo, S.
|
|
2017
|
73 |
C |
p. 1-8
8 p.
|
artikel
|
| 7 |
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
|
Wistuba-Hamprecht, Kilian
|
|
2017
|
73 |
C |
p. 61-70
10 p.
|
artikel
|
| 8 |
Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells
|
Tuchen, Marcus
|
|
2017
|
73 |
C |
p. 9-21
13 p.
|
artikel
|
| 9 |
Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
|
Janssens, Geert O.
|
|
2017
|
73 |
C |
p. 38-47
10 p.
|
artikel
|
| 10 |
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area
|
Liang, Hu
|
|
2017
|
73 |
C |
p. 48-60
13 p.
|
artikel
|
| 11 |
The mitogen-activated protein kinase pathway in melanoma part I – Activation and primary resistance mechanisms to BRAF inhibition
|
Amaral, Teresa
|
|
2017
|
73 |
C |
p. 85-92
8 p.
|
artikel
|
Tijdschrift beschrijving